Balcinrenone

DB15418InvestigationalSmall molecule

AZD-9977 is under investigation in clinical trial NCT03843060 (A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers).

Mechanism: Pharmacologically active on Mineralocorticoid receptor
Curator reviewed
Formula / weight: C₂₀H₁₈FN₃O₅ · 399.378 g/mol (avg)
Code names: AZD-9977

Resolves to

Compound

UNII6C9UKZ0CYECAS1850385-64-6ChEMBLCHEMBL3916929

Structure

InChIKeyMBKYLPOPYYLTNW-ZDUSSCGKSA-NSMILESCNC(=O)C[C@H]1COC2=C(C=CC(F)=C2)N1C(=O)C1=CC2=C(OCC(=O)N2)C=C1

Targets

P08235NR3C2

What you can answer from here — as of September 19, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

17Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Balcinrenone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account